Your session is about to expire
← Back to Search
Lifestyle Physical Activity for Metabolic Diseases
Study Summary
This trial is designed to study the effects of a new way of doing light physical activity - what we are calling "lifestyle physical activity" (LPA) - on specific and systemic metabolism. LPA is designed to be safe and practical for people to do every day, for prolonged periods of time throughout the day, and to be done while performing their daily activities.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are researchers looking for participants in this experiment at the moment?
"Clinicaltrials.gov states that this trial has concluded its recruitment efforts, with the original post date being August 1st 2016 and the last update on November 19th 2021. Although participation in this study is no longer possible, 1199 other clinical trials are currently accepting participants."
What are the primary goals of this research endeavor?
"This clinical trial's main aim is to measure the alteration in sedentary muscle time due to a single bout of contractile activity from the soleus. Secondary objectives involve observing changes in ferritin concentration (a biomarker linked with diabetes and inflammation), apolipoprotein B100 concentration, and electromyography results for triceps surae activation following an 8-12 hour fast."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger